Name:	O
___.	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Celebrex	O
/	O
Ativan	O
Attending:	O
___.	O
Chief	O
Complaint:	O
insomnia,	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status.	B-Delirium
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none.	O
History	O
of	O
Present	O
Illness:	O
This	O
is	O
a	O
___	O
year	O
old	O
female	O
with	O
a	O
history	O
___	O
body	O
dementia	B-Dementia
and	O
hypertension	O
who	O
was	O
brought	O
to	O
the	O
ED	O
by	O
her	O
son	O
with	O
3	O
days	O
of	O
insomnia	O
and	O
worsening	O
delirium.	B-Delirium
History	O
obtained	O
from	O
daughter	O
in	O
law	O
as	O
pt	O
has	O
dementia	B-Dementia
at	O
baseline	O
and	O
does	O
not	O
know	O
why	O
she	O
is	O
in	O
the	O
hospital.	O
Per	O
the	O
daughter	O
in	O
law,	O
pt	O
has	O
had	O
worsening	O
insomnia	O
for	O
the	O
last	O
few	O
days.	O
She	O
has	O
not	O
slept	O
in	O
over	O
3	O
days.	O
Her	O
children	O
are	O
concerned	O
that	O
this	O
may	O
be	O
a	O
manifestation	O
of	O
a	O
UTI	B-Urinary_tract_infection
as	O
she	O
has	O
had	O
several	O
UTIs	B-Urinary_tract_infection
in	O
the	O
past,	O
all	O
presenting	O
with	O
worsening	O
delirium	B-Delirium
without	O
urinary	O
symptoms.	O
She	O
also	O
notes	O
that	O
pt	O
has	O
had	O
ongoing	O
visual	O
and	O
auditory	O
hallucinations,	O
and	O
has	O
been	O
noted	O
to	O
be	O
"speaking	O
with	O
people	O
who	O
are	O
not	O
there."	O
Of	O
note,	O
her	O
family	O
notes	O
that	O
the	O
patient	O
is	O
confused	B-Delirium
at	O
baseline,	O
oriented	O
x	O
___.	O
Pt	O
has	O
had	O
no	O
recent	O
medication	O
changes.	O
.	O
In	O
the	O
ED,	O
initial	O
vs	O
were:	O
T	O
96.3	O
P	O
84	O
BP	O
154/86	O
R	O
20	O
O2	O
99%	O
sat.	O
Patient	O
was	O
given	O
levofloxacin	O
750	O
IV	O
for	O
infiltrate	O
noted	O
on	O
cx-ray	O
(ED	O
read,	O
radiology	O
read	O
pending).	O
.	O
On	O
the	O
floor,	O
pt	O
reports	O
feeling	O
cold.	O
But	O
otherwise	O
denies	O
chest	O
pain,	O
shortness	O
of	O
breath,	O
dysuria,	O
increased	O
urinary	O
frequency	O
or	O
any	O
other	O
symptoms.	O
Past	O
Medical	O
History:	O
Dementia,	B-Dementia
___	O
Body	O
dementia	B-Dementia
Hypertension	O
h/o	O
DVT,	O
PE	O
treated	O
with	O
IVC	O
filter	O
___	O
Glaucoma	B-Visual_impairment
s/p	O
bilateral	O
cataracts	O
surgery	O
Right	O
total	O
knee	O
arthroplasty	O
approximately	O
___	O
years	O
ago	O
h/o	O
Right	O
hip	B-Hip_fracture
fracture	B-Hip_fracture
Cholecystitis	O
c/b	O
bile	O
duct	O
perforation	O
in	O
___	O
s/p	O
TAH/BSO	O
History	O
of	O
hemorrhoids.	O
VRE-bacteremia	I-Urinary_tract_infection
in	O
past	O
and	O
in	O
urine	B-Urinary_tract_infection
appendectomy	O
breast	O
lumpectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother	O
died	O
of	O
breast	O
CA	O
at	O
___.	O
Father	O
died	O
of	O
MI	O
in	O
___.	O
Pt	O
has	O
extensive	O
family	O
with	O
7	O
siblings.	O
Physical	O
Exam:	O
VS:	O
96.4	O
BP:130/80	O
HR	O
88	O
99%	O
RA	O
RR	O
20	O
Gen:	O
Pleasant	O
elederly	O
female,	O
in	O
NAD	O
HEENT:	O
AT/NC,	O
EOMI,	O
MMM,	O
no	O
LAD	O
Neck:	O
Supple,	O
no	O
JVD	O
Cor:	O
RRR	O
nl	O
s1,	O
s2	O
no	O
m/r/g	O
Pulm:	O
Bibasilar	O
crackles	O
(R>L),	O
intermittent	O
end-expiratory	O
wheezing	O
Abd:	O
Soft,	O
+BS,	O
NT/ND,	O
no	O
HSM.	O
Extrem:	O
No	O
edema	O
Skin:	O
No	O
rash	O
Neuro:	O
AOx1,	B-Unspecified_cognitive_impairment
thinks	O
she	O
is	O
at	O
home,	O
in	O
___.	O
Pt	O
remembers	O
her	O
birthdate	O
and	O
were	O
she	O
grew	O
up.	O
Concentration	O
good	O
(days	O
of	O
week	O
backward).	O
Remembers	O
___	O
wors	O
after	O
1	O
min.	O
Poor	O
calculation.	O
Motor	O
___	O
throughout	O
UE.	O
RLE	O
weaker	O
than	O
LLE	O
but	O
poor	O
cooperation.	O
reflex	O
2+	O
throughout.	O
Sensation	O
intact.	O
Pertinent	O
Results:	O
___	O
01:55AM	O
URINE	O
Color-Yellow	O
Appear-Clear	O
Sp	O
___	O
___	O
08:40PM	O
URINE	O
Color-Yellow	O
Appear-Clear	O
Sp	O
___	O
___	O
01:55AM	O
URINE	O
Blood-SM	O
Nitrite-NEG	O
Protein-TR	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-1	O
pH-7.0	O
Leuks-NEG	O
___	O
08:40PM	O
URINE	O
Blood-SM	O
Nitrite-NEG	O
Protein-30	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-1	O
pH-6.5	O
Leuks-NEG	O
___	O
01:55AM	O
URINE	O
___	O
Bacteri-NONE	O
Yeast-NONE	O
___	O
08:00PM	O
BLOOD	O
WBC-6.9	O
RBC-4.08*	O
Hgb-10.0*	O
Hct-33.3*	O
MCV-82	O
MCH-24.6*	O
MCHC-30.1*	O
RDW-14.5	O
Plt	O
___	O
___	O
07:00PM	O
BLOOD	O
WBC-6.4	O
RBC-4.02*	O
Hgb-10.0*	O
Hct-32.8*	O
MCV-81*	O
MCH-24.8*	O
MCHC-30.5*	O
RDW-14.5	O
Plt	O
___	O
___	O
08:00PM	O
BLOOD	O
Plt	O
___	O
___	O
08:00PM	O
BLOOD	O
Glucose-105	O
UreaN-20	O
Creat-0.6	O
Na-140	O
K-3.8	O
Cl-105	O
HCO3-29	O
AnGap-10	O
.	O
Studies:	O
CXR:	O
shows	O
no	O
signs	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
.	O
Head	B-Intracranial_haemorrhage
CT:	O
1.	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
process	O
(though	O
evaluation	O
is	O
limited,	O
due	O
to	O
severe	O
underlying	O
microvascular	O
infarction).	O
2.	O
Central	O
atrophy	O
with	O
moderate	O
ventriculomegaly	O
and	O
dilatation	O
of	O
Virchow-	O
___	O
spaces	O
within	O
bilateral	O
basal	O
ganglia,	O
likely	O
representing	O
so-called	O
"etat	O
crible"	O
also	O
related	O
to	O
chronic	O
small	O
vessel	O
ischemia.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
w	O
h/o	O
htn,	O
___	O
body	O
dementia	B-Dementia
and	O
recurrent	O
UTI,	B-Urinary_tract_infection
p/w	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
in	O
the	O
setting	O
of	O
insomnia	O
x3days.	O
Confusion	B-Delirium
in	O
this	O
elderly	O
patient	O
could	O
be	O
triggered	O
by	O
her	O
h/o	O
insomnia,	O
a	O
new	O
infection,	O
new	O
medication	O
or	O
progression	O
of	O
her	O
underlying	O
dementia.	B-Dementia
In	O
terms	O
of	O
an	O
infectious	O
work-up,	O
the	O
patient	O
denied	O
any	O
localizing	O
symptoms	O
and	O
had	O
a	O
negative	O
CXR.	O
An	O
initial	O
UA	O
revealed	O
the	O
presence	O
of	O
___	O
WBCs	O
but	O
was	O
negative	O
for	O
nitrates	O
and	O
LEs.	O
A	O
head	O
CT	O
was	O
negative	O
for	O
any	O
acute	O
processes.	O
Finally,	O
the	O
patient	O
has	O
also	O
not	O
been	O
on	O
new	O
prescription	O
medications,	O
although	O
the	O
daughter	O
in	O
law	O
mentioned	O
giving	O
the	O
patient	O
2	O
0.5mg	O
ativan	O
yesterday.	O
It	O
was	O
felt	O
that	O
her	O
mental	B-Delirium
status	B-Delirium
change	B-Delirium
and	O
agitation	B-Dementia
may	O
have	O
been	O
triggered	O
by	O
her	O
insomnia	O
and/or	O
the	O
ativan	O
as	O
well	O
as	O
a	O
probably	O
UTI.	B-Urinary_tract_infection
.	O
On	O
the	O
morning	O
of	O
discharge,	O
the	O
patient	O
mental	O
status	O
was	O
felt	O
to	O
be	O
at	O
baseline.	O
The	O
patient	O
was	O
placed	O
on	O
a	O
3	O
day	O
course	O
of	O
ciprofloxacin	O
for	O
treatment	O
of	O
a	O
likely	O
UTI.	B-Urinary_tract_infection
The	O
patient's	O
family	O
was	O
contacted	O
and	O
instructed	O
to	O
monitor	O
the	O
patient's	O
sleep	O
wake	O
cycle	O
to	O
minimize	O
day-time	O
sleep.	O
Completed	O
by	O
___,	O
MS4	O
Medications	O
on	O
Admission:	O
1.	O
Metoprolol	O
Succinate	O
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
2.	O
Erythromycin	O
5	O
mg/g	O
Ointment	O
Sig:	O
One	O
(1)	O
Ophthalmic	O
QID	O
(4	O
times	O
a	O
day).	O
3.	O
Aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
Discharge	O
Medications:	O
1.	O
Metoprolol	O
Succinate	O
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
2.	O
Erythromycin	O
5	O
mg/g	O
Ointment	O
Sig:	O
One	O
(1)	O
Ophthalmic	O
QID	O
(4	O
times	O
a	O
day).	O
3.	O
Aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
4.	O
Cipro	O
250	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
every	O
twelve	O
(12)	O
hours	O
for	O
3	O
days.	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary:	O
-	O
Change	O
in	O
mental	O
status.	O
.	O
Secondary:	O
-	O
___	O
body	O
dementia.	B-Dementia
-	O
Hypertension.	O
Discharge	O
Condition:	O
stable.	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
for	O
insomnia	O
and	O
change	O
in	O
your	O
thinking.	O
We	O
felt	O
that	O
your	O
change	O
in	O
awarness	O
was	O
the	O
result	O
of	O
your	O
insomnia.	O
Imaging	O
of	O
your	O
chest	O
showed	O
that	O
you	O
did	O
not	O
have	O
a	O
pneumonia.	B-Lower_respiratory_tract_infection
Analysis	O
of	O
your	O
urine	O
showed	O
no	O
signs	O
of	O
a	O
urinary	B-Urinary_tract_infection
track	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
We	O
decided	O
to	O
treat	O
you	O
prophylactically	O
for	O
a	O
urinary	B-Urinary_tract_infection
track	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
with	O
ciprofloxacin.	O
.	O
Please	O
continue	O
taking	O
ciprofloxacin	O
for	O
three	O
days.	O
First	O
day	O
was	O
___.	O
.	O
Please	O
monitor	O
the	O
patient's	O
sleep	O
wake	O
cycle	O
to	O
minimize	O
day-time	O
sleep.	O
We	O
do	O
not	O
recommend	O
to	O
give	O
any	O
sedative	O
(especially	O
benzodiazepines,	O
like	O
ativan)	O
as	O
they	O
may	O
increase	O
agitation	O
in	O
elderly	O
people.	O
.	O
In	O
the	O
future,	O
please	O
return	O
to	O
the	O
emergency	O
room	O
if	O
you	O
experience	O
confusion,	B-Delirium
lethargy,	O
fever,	O
pain	O
on	O
urination	O
or	O
blood	O
in	O
your	O
urine.	O
Followup	O
Instructions:	O
___	O

